Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three antibiotics—cefotaxime, cefuroxime, and gentamicin—with the corticosteroid prednisolone. - Cefotaxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria[2]. - Cefuroxime is a second-generation cephalosporin antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative organisms; it also acts by inhibiting bacterial cell wall synthesis[4]. - Gentamicin is an aminoglycoside antibiotic that binds to the 30S subunit of bacterial ribosomes, inhibiting protein synthesis and causing misreading of mRNA, which results in bactericidal effects. - Prednisolone is a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties; it acts primarily through glucocorticoid receptor agonism to modulate gene expression involved in inflammation. This combination may be used in clinical settings where both potent antibacterial coverage (including for severe or mixed infections) and anti-inflammatory action are required (e.g., certain ophthalmic surgeries or severe infections). The compatibility of such combinations must be carefully considered due to potential drug interactions or aggregate formation[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cefotaxime + cefuroxime + gentamicin + prednisolone.